Compare IOP Reduction

15 products »

close Created with Sketch.

Trusopt

Merck

Trusopt (dorzolamide hydrochloride ophthalmic solution) 2% is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

At-a-Glance
  • Mechanism of Action: Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in intraocular pressure (IOP).
  • Dosage: One drop in the affected eye(s) three times daily

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Dorzolamide hydrochloride

Application

Topical

Status

Prescription

Strength

2%

Company Information

Contact the company for additional information, availability, or pricing:

Merck

www.merck.com

2000 Galloping Hill Road

Kenilworth, NJ 07033